Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2026 -89.96M
June 30, 2026 -1.992M
March 31, 2026 -4.081M
December 31, 2025 -3.764M
September 30, 2025 -7.096M
June 30, 2025 -10.80M
March 31, 2025 -11.46M
December 31, 2024 -8.999M
September 30, 2024 -8.51M
June 30, 2024 -8.481M
March 31, 2024 -7.982M
December 31, 2023 -5.137M
September 30, 2023 -5.152M
June 30, 2023 -9.574M
March 31, 2023 -5.478M
December 31, 2022 -3.875M
September 30, 2022 -7.125M
June 30, 2022 -8.225M
March 31, 2022 -9.975M
December 31, 2021 -10.02M
Date Value
September 30, 2021 -17.54M
June 30, 2021 -16.26M
March 31, 2021 -12.55M
December 31, 2020 -25.38M
September 30, 2020 -23.64M
June 30, 2020 -35.86M
March 31, 2020 -52.21M
December 31, 2019 -22.25M
September 30, 2019 -21.79M
June 30, 2019 -12.72M
March 31, 2019 -16.64M
December 31, 2018 -16.62M
September 30, 2018 -12.17M
June 30, 2018 -12.65M
March 31, 2018 -11.29M
December 31, 2017 -10.19M
September 30, 2017 -12.51M
June 30, 2017 0.037M
March 31, 2017 -5.584M
December 31, 2016 -4.549M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. -2.902M
Cue Biopharma, Inc. -10.08M
Faeth Therapeutics, Inc. -13.00M
Indaptus Therapeutics, Inc. -1.245M
Pyxis Oncology, Inc. -16.29M